NCT02243605 2026-03-18
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
St. Jude Children's Research Hospital
Eli Lilly and Company